[go: up one dir, main page]

WO2016116909A3 - Compositions de gel topique non tachantes de nimésulide - Google Patents

Compositions de gel topique non tachantes de nimésulide Download PDF

Info

Publication number
WO2016116909A3
WO2016116909A3 PCT/IB2016/050355 IB2016050355W WO2016116909A3 WO 2016116909 A3 WO2016116909 A3 WO 2016116909A3 IB 2016050355 W IB2016050355 W IB 2016050355W WO 2016116909 A3 WO2016116909 A3 WO 2016116909A3
Authority
WO
WIPO (PCT)
Prior art keywords
nimesulide
topical gel
gel compositions
compositions
staining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2016/050355
Other languages
English (en)
Other versions
WO2016116909A2 (fr
Inventor
Lalatendu Panigrahi
Alok Ranjan SAMAL
Mahesh KATARIYA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Priority to RU2017129736A priority Critical patent/RU2711090C2/ru
Priority to UAA201708570A priority patent/UA121985C2/uk
Publication of WO2016116909A2 publication Critical patent/WO2016116909A2/fr
Publication of WO2016116909A3 publication Critical patent/WO2016116909A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des compositions de gel topique non tachantes de nimésulide. L'invention concerne également les procédés de préparation de telles compositions. En outre, l'invention concerne l'utilisation de ces compositions pour le traitement de la douleur et de symptômes inflammatoires associés au système musculo-squelettique, à l'arthrose et la polyarthrite rhumatoïde.
PCT/IB2016/050355 2015-01-23 2016-01-25 Compositions de gel topique non tachantes de nimésulide Ceased WO2016116909A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2017129736A RU2711090C2 (ru) 2015-01-23 2016-01-25 Неокрашивающая гелевая композиция, содержащая нимесулид, для местного применения
UAA201708570A UA121985C2 (uk) 2015-01-23 2016-01-25 Нефарбуюча гелева композиція для місцевого застосування, яка містить німесулід

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN346/CHE/2015 2015-01-23
IN346CH2015 2015-01-23

Publications (2)

Publication Number Publication Date
WO2016116909A2 WO2016116909A2 (fr) 2016-07-28
WO2016116909A3 true WO2016116909A3 (fr) 2016-10-27

Family

ID=56417894

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2016/050355 Ceased WO2016116909A2 (fr) 2015-01-23 2016-01-25 Compositions de gel topique non tachantes de nimésulide

Country Status (3)

Country Link
RU (1) RU2711090C2 (fr)
UA (1) UA121985C2 (fr)
WO (1) WO2016116909A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7155123B2 (ja) 2016-08-31 2022-10-18 タロ ファーマシューティカル インダストリーズ エルティディ． 皮膚疾患を治療するためのフェノルドパム局所製剤
EP4218719A3 (fr) * 2019-03-08 2023-09-20 Taro Pharmaceutical Industries Ltd. Compositions topiques stables de fenoldopam

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022917A2 (fr) * 1999-09-28 2001-04-05 Panacea Biotec Limited Compositions effervescentes comportant du nimesulide
WO2010038240A1 (fr) * 2008-09-30 2010-04-08 Panacea Biotec Limited Composition pharmaceutique comprenant du nimésulide et de la lévocétirizine
EP2514409A1 (fr) * 2011-04-19 2012-10-24 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Compositions pharmaceutiques locales de nimésulide et méthylsulfonylméthane

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1289973B1 (it) * 1997-02-25 1998-10-19 Helsinn Healthcare Sa Sistemi gelificati di nimesulide per uso topico
US20040156872A1 (en) * 2000-05-18 2004-08-12 Elan Pharma International Ltd. Novel nimesulide compositions
RU2260432C1 (ru) * 2004-10-12 2005-09-20 Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") Средство для лечения болезней суставов
WO2008049020A2 (fr) * 2006-10-17 2008-04-24 Nuvo Research Gel de diclofénac
US20120004200A1 (en) * 2008-12-23 2012-01-05 Galderma S.A. Topical pharmaceutical composition containing a water-sensitive active principle

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022917A2 (fr) * 1999-09-28 2001-04-05 Panacea Biotec Limited Compositions effervescentes comportant du nimesulide
WO2010038240A1 (fr) * 2008-09-30 2010-04-08 Panacea Biotec Limited Composition pharmaceutique comprenant du nimésulide et de la lévocétirizine
EP2514409A1 (fr) * 2011-04-19 2012-10-24 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Compositions pharmaceutiques locales de nimésulide et méthylsulfonylméthane

Also Published As

Publication number Publication date
RU2711090C2 (ru) 2020-01-15
WO2016116909A2 (fr) 2016-07-28
RU2017129736A3 (fr) 2019-06-18
UA121985C2 (uk) 2020-08-25
RU2017129736A (ru) 2019-02-25

Similar Documents

Publication Publication Date Title
ZA202004557B (en) Modulatory polynucleotides
WO2016011306A3 (fr) Modifications de terminal de polynucléotides
WO2017011820A3 (fr) Peptides inhibiteurs du récepteur de l'interleukine-23 et leur utilisation pour traiter des maladies inflammatoires
WO2015179559A3 (fr) Composés de pyrazole, procédés de production et utilisation
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
WO2016170348A8 (fr) Compositions de petits arn et méthodes d'utilisation
HK1249104A1 (zh) 作为HDAC8抑制剂的α-肉桂酰胺化合物和组合物
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
WO2015085318A3 (fr) Vaccins adaptatifs ciblés
WO2017112528A3 (fr) Compositions d'interleukine-15 et leurs utilisations
EP3256438A4 (fr) Composés, compositions, et procédés de traitement de maladies inflammatoires, dégénératives, et neurodégénératives
HK1243935A1 (zh) 有机化合物
MY193175A (en) Apremilast pharmaceutical compositions
WO2015187521A3 (fr) Anticorps anti-blys
MX2021010472A (es) Anticuerpos neutralizantes de gm-csf para usarse en el tratamiento de artritis reumatoide o como analgesicos.
WO2016140859A3 (fr) Variants de protoxine ii et méthodes d'utilisation
PH12018500358A1 (en) Compounds for use in an antibacterial applications
HK1221425A1 (zh) 芋螺毒素(conotoxin)肽，其医药组合物和用途
AU2016298962A8 (en) Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
WO2017087917A3 (fr) Biocapteurs de bicarbonate, biocapteurs de calcium et leurs utilisations

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2017/0691.1

Country of ref document: KZ

WWE Wipo information: entry into national phase

Ref document number: A201708570

Country of ref document: UA

ENP Entry into the national phase

Ref document number: 2017129736

Country of ref document: RU

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 16739872

Country of ref document: EP

Kind code of ref document: A2